DAWN
NASDAQ · Biotechnology
Day One Biopharmaceuticals I
$21.53
+0.00 (+0.00%)
Analyst Consensus
Hold
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+161.4% upside
Low Target
$41.40
Average Target
$56.28
High Target
$65.73
Current Price
$21.53
Current
$21.53
$21.53
Target
$56.28
$56.28
$41.40
$56.28 avg
$65.73
Scenario Analysis
Bear Case
$41.40
92.3%
Low target
Base Case
$56.28
+161.4%
Avg target
Bull Case
$65.73
+205.3%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$21.53
0.0% from high
52-Week Low
$7.11
+203.0% from low
Target vs 52W High
$56.28
+161.4% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |